(-0.17%) 5 460.20 points
(-0.36%) 38 971 points
(0.19%) 17 751 points
(0.41%) $81.16
(-3.48%) $2.66
(-0.94%) $2 309.00
(-0.37%) $28.76
(1.34%) $999.60
(0.24%) $0.935
(0.84%) $10.69
(0.35%) $0.791
(-0.28%) $87.24
Live Chart Being Loaded With Signals
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer...
Stats | |
---|---|
本日の出来高 | 7 099 |
平均出来高 | 0 |
時価総額 | 15.43M |
EPS | $-0.0844 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Cogley Brian | Buy | 5 000 | Common Stock |
2024-01-10 | Cogley Brian | Sell | 0 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 1 800 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 466 | Common Stock |
2024-01-05 | Yerace Daniel Alexander | Buy | 10 850 | Common Stock |
INSIDER POWER |
---|
-74.77 |
Last 21 transactions |
Buy: 105 996 | Sell: 1 403 923 |
Coeptis Therapeutics 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Coeptis Therapeutics 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2023 |
収益: | $0 |
総利益: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2022 |
収益: | $0 |
総利益: | $-1.00M (0.00 %) |
EPS: | $-2.87 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn\'s disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson\'s Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。